
Severe ehrlichiosis is characterized by fulminant acute liver injury that frequently culminates in multi-organ failure, yet the mechanisms governing defective hepatic regeneration remain poorly understood. Using complementary in vitro systems and established murine models of mild (Ehrlichia muris) and severe (Ehrlichia japonica) infection, we identified differential regulation of the canonical Wnt/β-catenin pathway as a central determinant of disease outcome. Mild E. muris infection elicited robust activation of Wnt/β-catenin signaling through macrophage-derived Wnt ligands, promoting β-catenin nuclear translocation in hepatocytes, transcription of regenerative target genes, and marked hepatocyte proliferation. In contrast, severe E. japonica infection profoundly suppressed Wnt/β-catenin signaling despite extensive hepatic macrophage accumulation, resulting in impaired liver regeneration, progressive liver injury, and fatal disease. Mechanistically, this suppression was driven by diminished macrophage-derived Wnt ligand production, aberrant hepatocyte mTORC1 activation that inhibited β-catenin signaling, and potentially the absence of a Wnt-mimetic Ehrlichia effector capable of engaging Frizzled receptors and sustaining regenerative signaling. Therapeutically, pharmacologic activation of β-catenin combined with doxycycline treatment of E. japonica infected mice restored canonical Wnt signaling, reduced bacterial burden and hepatic injury, and significantly improved survival. Collectively, these findings establish impaired Wnt/β-catenin signaling as a pivotal mechanism underlying impaired liver regeneration during severe ehrlichiosis and identify restoration of this pathway as a promising host-directed therapeutic strategy that complements antimicrobial therapy by simultaneously promoting pathogen clearance and hepatic repair.